Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Basel Medical Group Ltd ( (BMGL) ) is now available.
On December 1, 2025, Basel Medical Group Ltd announced it received a delinquency notification from Nasdaq due to an incomplete annual report for the fiscal year ending June 30, 2025, which lacked an auditor’s opinion. The company has 60 days to submit a compliance plan to Nasdaq, potentially extending up to 180 days to rectify the issue. Despite the filing delinquency, the trading of the company’s shares on Nasdaq remains unaffected, and Basel Medical is actively working with professionals to address the non-compliance.
More about Basel Medical Group Ltd
Basel Medical Group Ltd is a Singapore-based provider specializing in orthopedic and trauma services, sports medicine, orthopedic procedures and surgery, neurosurgical treatments, and a range of other health services including executive health screening, occupational medicine, rehabilitation, mental and women’s health, and general practices. With over 20 years of experience, the company operates multiple clinics in Singapore and has established strong relationships with corporations in the construction, marine, and oil & gas industries, positioning itself to capitalize on growth opportunities in the private healthcare sector across Southeast Asia.
Average Trading Volume: 97,042
Technical Sentiment Signal: Strong Sell
Current Market Cap: $22.36M
Learn more about BMGL stock on TipRanks’ Stock Analysis page.